Diethylstilbestrol - Wikipedia Diethylstilbestrol (DES), also known as stilbestrol or stilboestrol, is a nonsteroidal estrogen medication [5][6][7] Its use is now rare; in the past, it was widely used for a variety of indications, including pregnancy support for those with a history of recurrent miscarriage, hormone therapy for menopausal symptoms and estrogen deficiency
Diethylstilbestrol (DES) Exposure and Cancer - NCI A fact sheet about the drug DES (diethylstilbestrol), a synthetic form of estrogen, and the health issues, including cancer risks, of people prenatally exposed to it Provides information on follow up for DES-exposed individuals, current research on DES exposure, and additional resources for people exposed to DES while pregnant or prenatally
What Is Diethylstilbestrol (DES) and Who Was Exposed? Diethylstilbestrol, commonly called DES, is a synthetic form of estrogen first produced in 1938 It was prescribed to millions of pregnant women from the mid-1940s through the early 1970s to prevent miscarriage In 1971, it was linked to a rare vaginal cancer in the daughters of women who took it, and the FDA pulled it from use in pregnancy Today it is classified as a known human carcinogen
Diethylstilbestrol and its Multigenerational Effects - AWIS Diethylstilbestrol (DES) was once thought to be a “wonder drug” that reduced complications in pregnancy It is now known as an endocrine disruptor and exposure to it causes carcinogenic effects that can continue through several generations
Are the Effects of DES Over? A Tragic Lesson from the Past Diethylstilbestrol (DES), a transplacental endocrine-disrupting chemical, was prescribed to pregnant women for several decades The number of women who took DES is hard to know precisely, but it has been estimated that over 10 million people have
Calendar